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SObjective: Patients with idiopathic pulmonary hypertension are at risk for right-sided heart failure and sudden
death. Despite improvement in pharmacologic management, some still require lung transplantation. Potts anas-
tomosis has been demonstrated as a good palliation in children to alleviate symptoms and medical therapy de-
spite desaturation in the lower part of the body. Young adult patients with pulmonary hypertension and
isosystemic pressure remain at risk, particularly at exercise. The goal of this research was to find a palliation
for patients in whom suprasystemic pulmonary hypertension developed at exercise. Creating a Potts anastomosis
involved a unidirectional valve between the left pulmonary artery and the descending aorta.
Methods: Experimental study was performed on 14 pigs. A prosthetic patch of polytetrafluoroethylene
(Gore-Tex; WL Gore & Associates Inc, Newark, Del) was used to create the unidirectional valve and implanted
in the Potts anastomosis. Via a left thoracotomy, an aorto-aortic shunt between the aortic isthmus and the distal
descending thoracic aortawas instituted, allowing a safe surgical procedure. Intrapulmonary injection of Erciplex
glue (Peters Surgical, Bobigny, France), diluted in 70% alcohol, was used to create acute pulmonary hyperten-
sion. The right to left shunt across the unidirectional valvular patch was evaluated after clamping the aorta in the
acute phase of pulmonary hypertension by echo-pulsed Doppler at the level of the descending thoracic aorta by
withdrawal of blood gas (arterial carbon dioxide tension, alveolar carbon dioxide tension) and assessment of pe-
ripheral oxygen saturation. Similar reevaluation of the shunt was performed at amean interval of 13 2.5 weeks.
Results: In the first series, Erciplex glue increased pulmonary artery pressure from 15.3 3.1 mm Hg to 38.7
6.0 mmHg.Mean peripheral oxygen saturation decreased from 100% to 85% 1.5%. Mean partial pressure of
carbon dioxide increased from 31.9 9.1 mmHg to 46.2 12.5 mmHg after shunt opening (P<.01), and mean
peripheral oxygen decreased from 435.1 109.4 mm Hg to 261.9 77.9 mm Hg (P<0.05), indicating right to
left shunt through the Potts valve (P<.013). Pulsed Doppler showed a mean peak laminar flow of 133.3  35.3
cm/s before aortic clamping, turbulent flow of 234.9 40.1 cm/s after glue injection, and return of laminar flow
128.5 30.1 cm/s after aortic isthmus unclamping. In the second series, the same results were obtained but with
a lesser peak flow velocity because of the endothelialization on the valvular patch. Gross analysis of the patch did
not show thrombosis, aneurysm, or fissure.
Conclusions: Palliation of exercise suprasystemic pulmonary hypertension was demonstrated by a unidirec-
tional valved Potts anastomosis. This technique can be of help in young adult patients with pulmonary hyper-
tension and isosystemic pressure but with exercise intolerance. (J Thorac Cardiovasc Surg 2011;142:1223-8)Primary pulmonary hypertension (PPH) may eventually
lead to right ventricular failure and death. Without treat-
ment, the mean survival after diagnosis is less than 1 year
in children1,2 and 2 to 3 years in adults.2,3 Patients with
severe right-sided heart failure (New York Heart Associa-
tion class IV) have the worst prognosis, with a median sur-
vival of 6 months.4 Right atrial pressure, pulmonary arterye Department of Congenital Heart Defects Surgery, Laboratory of Experi-
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The Journal of Thoracic and Carpressure, and cardiac index have been shown to correlate
with mortality.1
The introduction of new pharmacologic agents has con-
siderably improved patient survival.5-9 Calcium blockers,
prostaglandin E1,10-12 endothelin receptor antagonists,13,14
and nitric oxide are well used in this subset of patients.15 Pa-
tients with PPH who have recurrent syncope, severe right-
sided heart failure, or both have a worse prognosis because
they generally have an intact interatrial septum.3 Longer sur-
vival has been described in patients with PPH who have an
interatrial communication.4 With sufficient right-to-left
shunting through an interatrial communication, cardiac out-
put can bemaintained or increased as needed, despite severe
pulmonary vascular disease. Furthermore, right-to-left
shunting at the atrial level allows decompression of the right
atrium and right ventricle, alleviating signs and symptoms of
right-sided heart failure.2 These hemodynamic changes arediovascular Surgery c Volume 142, Number 5 1223
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Sassociated with decreased systemic arterial saturation but
improved oxygen transport. These findings have prompted
several authors to perform an atrial blade septostomy to de-
compress right-sided heart cavities and to improve systemic
output1,2; however, this procedure is associated with a low
rate of success in patients with severe right-sided heart
failure because of profound systemic desaturation. Finally,
double lung or heart lung transplantation is an option, but
shortage of organ donors and chronic rejection remain seri-
ous drawbacks to this procedure.16
On the other hand, patients with Eisenmenger syndrome
demonstrate a longer survival until 50 years of age,1,4
particularly when the cardiac cause is as simple as a patent
ductus arteriosus. Therefore, the idea to convert primitive
pulmonary hypertension into Eisenmenger’s pattern by
creating a communication between pulmonary and aortic
vascular beds, namely, a Potts anastomosis, should
theoretically improve the survival and quality of life. This
procedure was recently reported in 2 patients with
terminal pulmonary arterial hypertension (PAH), in whom
an anastomosis was created between the left pulmonary
artery (LPA) and the descending aorta (ie, Potts
anastomosis) long after an arterial switch operation for
transposition of the great vessels.17 Both patients recovered,
and right and left ventricular pressures were equalized. We
also performed this procedure on 9 critically ill children
with good early andmidterm results.18 Indications for a stan-
dard Potts anastomosis should therefore include patients
with suprasystemic intractable pulmonary hypertension.
There is, however, a large category of patients with PPH
well stabilized by medical treatment who demonstrate iso-
systemic pulmonary artery pressures at rest that increase
for minimal exercise and therefore present an intolerance
for minimal exercise.
To palliate this subgroup of patients, we designed an an-
imal model of PPH in which a unidirectional valved Potts
anastomosis allows right to left shunting during a suprasys-
temic pulmonary hypertensive crisis and no shunting when
pulmonary arterial pressures are isosystemic.MATERIALS AND METHODS
All animals received humane care in compliance with the ‘‘Guide for
the Care and Use of Laboratory Animals’’ (www.nap.edu/catalog/5140.
html). Pigs (n ¼ 9) with a mean weight of 29.3  4.2 kg underwent induc-
tion of anesthesia with intramuscular ketamine (10 mg/kg) and atropine
(0.04 mg/kg) and were intubated with a cuffed endotracheal tube. Animals
were ventilated with a melange of air and oxygen (21%). Anesthesia was1224 The Journal of Thoracic and Cardiovascular Surmaintained with inhalation of 1% to 2% isoflurane. In addition, pancuro-
nium 0.1 mg/kg and nalbuphine 0.2 mg/kg were administered for muscle
relaxation. Antibioprophylaxy was achieved by cefotaxime 1 g and genta-
micin 80 mg twice. A pressure monitoring catheter was placed in the right
femoral artery. Pulmonary artery and left thoracic artery pressures were
placed under direct vision. Electrocardiogram was recorded, and saturation
sensors were placed on the right ear and tail.
Induction of Pulmonary Hypertension
Previous results from our laboratory showed that in situ injection of
Erciplex glue (Peters Surgical, Bobigny, France), diluted at a proportion
of 2 to 1 in 70% alcohol to obtain less viscosity, 3 times 2 mL with an in-
terval of 7 minutes induces severe pulmonary hypertension for at least 15
minutes. Although the underlying mechanism is not well understood, clear
pulmonary hypertension developed.
Construction of Unidirectional Valve
The unidirectional valve was constructed with polytetrafluoroethylene
(Gore-Tex; WL Gore & Associates Inc, Newark, Del) patches (expanded
polytetrafluoroethylene cardiovascular patch 0.5 mm) by mimicking the
membrane of fossa ovalis. The unidirectional valve is made of 2 polytetra-
fluoroethylene (Gore-Tex) Acuseal or knitted Dacron double patches. One
patch is oval and one patch is semi-lunar, half of the circumference of the
first patch. The small patch is superposed to the oval one and sutured at its 2
horns. The polytetrafluoroethylene (Gore-Tex) 0.1-mm patch was not used
because it was too thin to support such hemodynamic patterns (Figure 1).Experimental Protocol and Surgical Technique
The animals were placed in the right decubitus position, and a left tho-
racotomy was made in the fourth intercostal space. The thoracic aorta from
the isthmus to diaphragm and the LPAwere mobilized and exposed. After
heparin administration (300 IU/kg), an aorto-aortic shunt was instituted be-
tween the aortic isthmus and the descending aorta close to the diaphragm
using right-angle cannulas. During the aorto-aortic shunt, the LPA and de-
scending aorta were crossclamped. An aortopulmonary anastomosis was
created between the LPA and the descending aorta, with a diameter of 10
to 12 mm and a length of 18 to 21 mm, and a unidirectional valve of differ-
ent tissues (Patch Acuseal Gore-Tex, 0.5 mm; tissue patch of knitted poly-
ester [Bard Sauvage Filamentous; Bard Peripheral Vascular, Inc, Tempe,
Ariz]; IMPRA [Bard Peripheral Vascular, Inc] expanded polytetrafluoro-
ethylene cardiovascular patch 0.5 mm) with adapted dimensions (mean
18.3  0.8 mm in length and 0.8  0.3 mm in width) was inserted into
this Potts anastomosis.
The concave side of the semi-lunar patch is sewed ‘‘en sandwich’’
between pulmonary aortic arteriotomies, and the half circumference of
the oval patch is also sewed ‘‘en sandwich’’ between pulmonary and aortic
arteriotomies, opposite to the semi-lunar patch. The oval patch is placed on
the systemic side, and the semi-lunar patch is placed on the pulmonary side
of the anastomosis. Half of the oval patch is therefore free floating in an
open position and is applied on the semi-lunar patch in a closed position.
Opening and closing of this valve are therefore dependent on the gradient
pressure between the aorta and the pulmonary artery (Figure 2).
After completion of the unidirectional valvular Potts anastomosis, the
descending aorta and the LPA were deaired and unclamped. Mean aortic
clamping time was 47  8.3 minutes, LPA time was 45  4.8 minutes,
mean intervention time for the valved Potts anastomosis was 137  26.6,
and aorto-aortic bypass timewas 71 12.4minutes. Hemodynamic param-
eters (blood pressure, heart rate) were monitored, as well as the oxygen
saturation and its changes in the pig’s ear and tail.
To induce PAH, Erciplex glue was injected through a number 16 cath-
eter into the LPA according to our previous protocol. One to 2 minutes after
the glue injection, the aortic isthmus was clamped completely between the
anastomosis and the superior cannula to obtain a suprasystemic pulmonarygery c November 2011
FIGURE 1. A, Unidirectional valve is constructed by a double patch. B, Oval patch on the systemic side. Semilunar patch on the pulmonary side.




Shypertension. Flow velocity of the right to left shunt across the valved patch
during the acute phase of pulmonary hypertension was measured by intra-
thoracic pulsed-Doppler ultrasound (1.9-MHz probe, Philips, Bothell,
Wash; Hewlett-Packard Sonos 100, Palo Alto, Calif) in the descending
aorta (Figure 3). Blood was taken from the descending aorta before and af-
ter the aortic clamping to evaluate changes of the arterial carbon dioxide
tension and alveolar carbon dioxide tension values. After decannulation
of the aorta, chest closure, and extubation, the animals were observed for
vital parameters and postoperative management until the reevaluation.
No antiaggregant treatment was started. Low-molecular-weight heparin,
enoxaparin sodium 0.4 mL (7500 UI) twice per day, was given the first
postoperative week and once per day the next week.
After a mean of 12 2.5 weeks, the right to left shunt was reevaluated in
the same manner as in the first experimental procedure but without the
aorto-aortic shunt. The animals were then killed for valve morphology
inspection.
Statistics
Results were calculated and presented as means standard deviation of
a minimum of 3 measurements in each animal. Statistical analysis was
achieved using the Student t test. Differences between the values were
calculated using SigmaPlot 11.0 (Systat Software Inc, San Jose, Calif).RESULTS
Glue injection allowed PAP to increase significantly
from a mean of 15.3  3.1 mm Hg before the procedure to
38.7 6.0 mmHg at the end of the procedure. PAP returnedFIGURE 2. Flow through the unidirectional valved Potts anastomosis. A, Ope
mic. B, Focus on unidirectional valve.Ao,Aorta (descending); LPA, left pulmona
SlP, semilunar patch.
The Journal of Thoracic and Carto the previous values (mean, 18.7 2.7mmHg) at the endof
the experimental procedure (P<.01), showing that the glue
injection effectively created conditions of PAH. Systemic
pressures, heart rate, and temperature were stable during
the aorto-aortic shunt and thoracic aorta crossclamping.
Under experimental conditions of suprasystemic PAH,
opening of the unidirectional valve in the Potts anastomosis
created a right to left shunt and led to a decrease in periph-
eral oxygen saturation on the tail to a mean of 85.7% 
1.5%. Peripheral oxygen decreased from a mean of 435.1
 109.4 mm Hg to 261.9  77.9 mm Hg, and alveolar car-
bon dioxide tension increased from 31.9  9.1 mm Hg to
46.2  12.5 mm Hg, indicating an effective right to left
shunt (P<.01).
By provoking PAH after the glue injection and clamping
the aortic isthmus, the pressure in the descending aorta de-
creased, permitting a turbulent flow at a higher velocity
from the LPA into the descending aorta across the unidirec-
tional valve of the Potts anastomosis, reflecting the sudden
augmentation of the pulmonary pressures. Maximum shunt
flow velocity in the descending aorta accelerated from
a mean of 133.3  35.5 cm/s before glue injection to
a mean of 234.9  40.1 cm/s after injection under aortic
clamping conditions (P< .001), and then returned to then position of unidirectional valve when pulmonary pressures is suprasyste-
ry artery;UdV, unidirectional valve; RLF, right to left flow;OvP, oval patch;
diovascular Surgery c Volume 142, Number 5 1225
FIGURE 3. Gross view of the explanted unidirectional valve from the LPA (A) and the aortic side (B) with a 7 Hegar probe through the valve.




Sprevious values after unclamping the aorta with a mean of
128.5  30.1 cm/s.
When the aortic isthmus was unclamped again, the pres-
sure in the descending aorta increased again, which dimin-
ished the shunt through the valved Potts anastomosis.
Subsequently, the flow velocity across the shunt decreased
progressively, once again becoming laminar after total
unclamping of the aortic isthmus.
Early complications included inferior paraplegia in 1 an-
imal 24 hours after the operation. The animal had to be
killed to examine the valved Potts anastomosis, which
was found to be undamaged. Another animal presenting
with signs of mesenteric microembolism died 36 hours
post-surgery. In the absence of any other cause, these find-
ings were correlated to a non-dissolving glue that was used
in our experiments. The other animals survived. We ob-
served no complications due to pulmonary thrombosis, no
distal or visceral embolism, and no PAH.
At reintervention, mean PAP increased significantly from
a mean of 15.9  2.8 mm Hg before to 46.7  11.4 mm Hg
after the glue injection and returned to the previous values
(mean, 20.3  2.8 mm Hg) at the end of the procedure
(P< .01), showing that the glue injection can effectively
create iterative PAH.Reevaluation of the Permeability of the Valved Potts
Anastomosis
Maximum shunt flow velocity in the descending aorta ac-
celerated from a mean of 109.9 38.0 cm/s before glue in-
jection to a mean of 171.0  30.2 cm/s after glue injection
under aortic clamping conditions (P<.001), and then re-
turned to previous values after unclamping the aorta with
a mean of 116.2  38.4 cm/s. Maximum velocities are
less elevated in the reintervention series compared with
those in the first series.Comparison of the Shunt Flow Between First and
Second Series
In both groups, the velocity of the right to left shunt
showed highly significant differences (P < .001) before
and after glue injection under clamping and unclamping1226 The Journal of Thoracic and Cardiovascular Surconditions, respectively. Therewas no significant difference
between the velocities before the glue injection and after
aortic unclamping, indicating that the flow changes in the
descending aorta were exclusively due to the flow shunt
through the unidirectional valve opening under the condi-
tions of PAH and in the presence of systemic arterial hypo-
tension due to the clamping of the aortic isthmus. The
differences in the peak velocity after glue injection were
significant in the 2 series (first series and reexaminations:
234.9  40.1 cm/s vs 171.5  30.2 cm/s, respectively;
P< .002). There were no differences between the peak
flow velocity before injection and after unclamping in either
of the groups.Surgical Evaluation of Valved Potts Anastomosis
After Reintervention
The morphologic examination of the valved anastomosis
at the end of the second series showed a preserved device
with no perforations, tearing, false aneurysms, or thrombo-
sis. A layer of intima or fibrin had formed progressively,
making the valve patch less flexible and therefore less per-
meable for the right to left shunt with a less wide orifice of
the unidirectional valve in some animals. This phenomenon
may be responsible for the decreased peak flow velocity of
the right to the left shunt in the reintervention series. The ef-
fective mean orifice size for shunting was 6.6  1.3 mm
(Figure 3).DISCUSSION
Primary PAH often has a fatal outcome because there is
no effective therapy. As a surgical palliative solution, crea-
tion of a right to left shunt has been proposed to relieve the
overload on the right ventricle, which allows a ventricular
septal shift from left to right, increasing the systemic left
ventricle filling and optimizing coronary perfusion. Such
a shunt has been proposed as an intracardiac right to left
shunt, created by perforation of the interatrial septum or
an extracardiac right to left shunt in the form of a Potts anas-
tomosis between the LPA and the descending aorta.
Whereas the interatrial shunt may be disadvantageous be-
cause of uncontrolled desaturation of the upper body andgery c November 2011




Scoronary and brain circulation, the Potts anastomosis bears
the risk of turning the right to left shunt from the pulmonary
artery into the aorta under PAH conditions into a left to right
shunt from the aorta into the pulmonary artery under condi-
tions of normal pressure conditions, thus being responsible
for a volume overload of the pulmonary circulation and in-
creasing pulmonary artery pressures and a steal phenome-
non from systemic to pulmonary circulation. Descriptions
of either method have been made rather sporadically in
the clinical field without illuminating the basic pathophys-
iologic processes. We therefore considered it necessary to
create an experimental animal model to outline the patho-
physiology and surgery of the Potts anastomosis in the field
of PAH.
Adult pigs weighing approximately 30 kg were preferred
to create the valved Potts anastomosis because they have
sufficient LPA dimensions (0.8–1.3 cm) to enable implanta-
tion of the unidirectional valve. Also, a bigger animal can
tolerate the experimental PAH created by the Erciplex
glue. The left thoracotomy at the fourth intercostal space
permits the best access to the vascular structures to be con-
nected. For the purpose of our protocol, which includes
clamping and unclamping the aorta to test the function of
the valve, to ensure a reproducible surgical technique, and
to maintain stability of systemic hemodynamics, an aorto-
aortic shunt was used. However, with increasing experience
and in clinical conditions of PAH, a simpler approach
avoiding aorto-aortic shunt should be possible.
It was important to find out the ideal dose and dilution of
the injected glue to avoid acute and irreversible right-sided
heart failure induced by massive PAH and at the same time
allow sufficient PAH to initiate the right to the left shunt
through the anastomosis. Dilution of the glue was also
necessary to avoid embolism of the systemic arteries of
the inferior body by overly large glue particles. The valve
inserted into the Potts anastomosis was created of double
patches sutured symmetrically into the LPA and the aorta
at the same time, and their dimension depended on the
dimension of the LPA.
In preliminary studies, itwas found thatGore-TexAcuseal
was the better material for constructing the patch because it
was the thinnest and smoothest, therefore guaranteeing a lon-
ger flexibility and functionality. The exact installation of the
unidirectional valve in the Potts anastomosis was important
to avoid an inversed shunt from the aorta into the LPA after
the creation of the anastomosis. The valved Potts anastomo-
sis should be placed as close as possible to the pulmonary ar-
terial bifurcation because the wider dimensions of the artery
allow an easier valved anastomosis and the more central
location of the anastomosis allows the pulmonary arterial
blood to drain correctly into the descending aorta.
When the descending aorta is completely clamped on the
level of the aortic isthmus, the right to left shunt starts to
work immediately under the conditions of PAH; subse-The Journal of Thoracic and Carquently, the pulmonary pressure decreases immediately
while the shunt is working. This guarantees stable hemody-
namics of the systemic circulation. Our experiments show
that the unidirectional valve in the Potts anastomosis allows
desaturated blood to drain from the LPA into the descending
aorta for discharge of the right ventricle under the condi-
tions of PAH, with left ventricle filling shown by stable in-
vasive blood pressure measurements, flow measurements
across the Potts shunt by pulsed Doppler, desaturation,
and increasing partial pressure of carbon dioxide in the in-
ferior body. As soon as the aortic circulation is stabilized,
the valve closes and normal conditions are reestablished
without shunt inversion.
The reintervention showed that the peak flow accelera-
tion was less marked than in the first series, which may be
due to the endothelialization phenomenon of the valve
that was covered with intima and fibrin layers, and therefore
more rigid and less permeable for the blood passing through
the shunt. Fibrin formation may induce platelet aggrega-
tion; therefore, antiaggregation treatment may help to avoid
thrombosis of the valve in the long-term, especially when
the valve opens less frequently. Reduction of the effective
orifice of the valve may be due to the closed position of
the valve during the interim period of 12 weeks. Indeed,
during this period the animals were in a normal hemody-
namic status with low pulmonary artery and high aortic
pressures. In the clinical field, one could anticipate that
such a device will open several times daily at any minimal
exercise, therefore maintaining a satisfactory effective
orifice.
The advantage of the intervention with a valved Potts
anastomosis is the immediate decompression of the over-
load of the right ventricle by creating a right to left shunt
on the arterial level that will not create cyanosis in the upper
half of the body. The desaturation caused by the right to left
shunt will be controlled automatically by the unidirectional
valve at the level of the anastomosis when the systemic
pressure increases again to values superior to those in the
pulmonary artery, without inversion of the shunt because
of the valve in the anastomosis. This intervention can thus
be applied in young patients with primary PAH and an intact
interatrial septum and suprasystemic exertional PAH. The
method also can be used in patients with so-called Eisen-
menger’s syndrome and profound cyanosis after intracar-
diac repair as a means to reduce upper-body cyanosis.
CONCLUSIONS
In the acute phase of PH, the unidirectional valve of the
Potts anastomosis opens when pulmonary arterial pressures
become suprasystemic and then creates a right to left shunt
at the arterial level, allowing discharge of the pulmonary
circulation into the descending aorta. The valve closes
when pulmonary arterial pressures return to isosystemic
or infrasystemic levels.diovascular Surgery c Volume 142, Number 5 1227
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